261 related articles for article (PubMed ID: 17312297)
1. Tamoxifen: an enduring star.
Veronesi U; Maisonneuve P; Decensi A
J Natl Cancer Inst; 2007 Feb; 99(4):258-60. PubMed ID: 17312297
[No Abstract] [Full Text] [Related]
2. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
Cuzick J; Forbes JF; Sestak I; Cawthorn S; Hamed H; Holli K; Howell A;
J Natl Cancer Inst; 2007 Feb; 99(4):272-82. PubMed ID: 17312304
[TBL] [Abstract][Full Text] [Related]
4. Does c-erbB2/HER2 overexpression predict adjuvant tamoxifen failure in patients with early breast cancer?
Hu JC; Mokbel K
Eur J Surg Oncol; 2001 Jun; 27(4):335-7. PubMed ID: 11417974
[No Abstract] [Full Text] [Related]
5. Raloxifene prevails in STAR trial, may face easier road to acceptance than previous drugs.
Vastag B
J Natl Cancer Inst; 2006 Jun; 98(11):733-5. PubMed ID: 16757696
[No Abstract] [Full Text] [Related]
6. Chemoprevention of breast cancer: recommendations and rationale.
Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459
[No Abstract] [Full Text] [Related]
7. Antiestrogens: the past and the future.
Bentrem DJ; Jordan VC
Zentralbl Gynakol; 2002 Dec; 124(12):551-8. PubMed ID: 12822068
[No Abstract] [Full Text] [Related]
8. Defining the role of raloxifene for the prevention of breast cancer.
Kalidas M; Hilsenbeck S; Brown P
J Natl Cancer Inst; 2004 Dec; 96(23):1731-3. PubMed ID: 15572750
[No Abstract] [Full Text] [Related]
9. Anti-oestrogenic prevention of breast cancer--the make or break point.
Powles TJ
Nat Rev Cancer; 2002 Oct; 2(10):787-94. PubMed ID: 12360281
[TBL] [Abstract][Full Text] [Related]
10. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
[TBL] [Abstract][Full Text] [Related]
11. Ovarian ablation as a treatment for breast cancer.
Sainsbury R
Surg Oncol; 2003 Dec; 12(4):241-50. PubMed ID: 14998564
[TBL] [Abstract][Full Text] [Related]
12. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
Powles TJ; Ashley S; Tidy A; Smith IE; Dowsett M
J Natl Cancer Inst; 2007 Feb; 99(4):283-90. PubMed ID: 17312305
[TBL] [Abstract][Full Text] [Related]
13. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
[No Abstract] [Full Text] [Related]
14. Re: Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.
Narasimhadevara R; Pollak MN; Foulkes WD
J Natl Cancer Inst; 2003 Jun; 95(12):917; author reply 918-9. PubMed ID: 12813177
[No Abstract] [Full Text] [Related]
15. [Estrogen and progesterone receptors in breast cancer].
Sonoo H
Nihon Rinsho; 2000 Apr; 58 Suppl():146-53. PubMed ID: 11025988
[No Abstract] [Full Text] [Related]
16. Tamoxifen in cancer therapy: minireview.
Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
[TBL] [Abstract][Full Text] [Related]
17. Re: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Cuzick J; Forbes JF; Howell A
J Natl Cancer Inst; 2006 May; 98(9):643; author reply 643-4. PubMed ID: 16670391
[No Abstract] [Full Text] [Related]
18. Tamoxifen treatment and new-onset depression in breast cancer patients.
Lee KC; Ray GT; Hunkeler EM; Finley PR
Psychosomatics; 2007; 48(3):205-10. PubMed ID: 17478588
[TBL] [Abstract][Full Text] [Related]
19. [The interruption of a study following an "ad interim" analysis. The example of the NSABP-P1 study].
Savarese A
Suppl Tumori; 2004; 3(4):S23-4. PubMed ID: 15206204
[No Abstract] [Full Text] [Related]
20. The current status of breast cancer chemoprevention: a star is born.
Morrow M; Jordan VC
J Surg Oncol; 2007 Jan; 95(1):4-5. PubMed ID: 17192883
[No Abstract] [Full Text] [Related]
[Next] [New Search]
